Lantheus Holdings, Inc. (LNTH)
99.97
-0.22
(-0.22%)
USD |
NASDAQ |
Oct 06, 16:00
99.97
0.00 (0.00%)
After-Hours: 20:00
Lantheus Holdings Cash from Investing (Quarterly) : -2.023M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.023M |
| March 31, 2026 | 25.99M |
| December 31, 2025 | -11.51M |
| September 30, 2025 | -319.47M |
| June 30, 2025 | -232.47M |
| March 31, 2025 | -63.72M |
| December 31, 2024 | -6.602M |
| September 30, 2024 | -67.80M |
| June 30, 2024 | -45.09M |
| March 31, 2024 | -106.53M |
| December 31, 2023 | -12.07M |
| September 30, 2023 | 83.22M |
| June 30, 2023 | -20.70M |
| March 31, 2023 | -44.51M |
| December 31, 2022 | -264.72M |
| September 30, 2022 | -6.09M |
| June 30, 2022 | -4.343M |
| March 31, 2022 | -1.39M |
| December 31, 2021 | -4.544M |
| September 30, 2021 | -2.42M |
| June 30, 2021 | -2.656M |
| March 31, 2021 | 13.30M |
| December 31, 2020 | -3.785M |
| September 30, 2020 | -3.736M |
| June 30, 2020 | 5.307M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.698M |
| December 31, 2019 | -4.741M |
| September 30, 2019 | -3.336M |
| June 30, 2019 | -3.434M |
| March 31, 2019 | -10.55M |
| December 31, 2018 | -7.366M |
| September 30, 2018 | -5.005M |
| June 30, 2018 | -5.626M |
| March 31, 2018 | -1.135M |
| December 31, 2017 | -5.954M |
| September 30, 2017 | -3.288M |
| June 30, 2017 | -2.503M |
| March 31, 2017 | -4.564M |
| December 31, 2016 | -2.358M |
| September 30, 2016 | -1.047M |
| June 30, 2016 | -0.736M |
| March 31, 2016 | 7.422M |
| December 31, 2015 | -4.732M |
| September 30, 2015 | -2.307M |
| June 30, 2015 | -2.614M |
| March 31, 2015 | -3.498M |
| December 31, 2014 | -2.834M |
| September 30, 2014 | -1.595M |
| June 30, 2014 | -1.791M |
| March 31, 2014 | -1.462M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biomerica, Inc. | 0.018M |
| Univec, Inc. | 0.00 |
| Indivior Pharmaceuticals, Inc. | -7.942M |
| Zomedica Corp. | 0.3581M |
| Bristol Myers Squibb Co. | -1.614B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 92.20M |
| Cash from Financing (Quarterly) | 4.505M |
| Free Cash Flow | 382.42M |
| Free Cash Flow Per Share (Quarterly) | 1.331 |
| Free Cash Flow to Equity (Quarterly) | 90.66M |
| Free Cash Flow to Firm (Quarterly) | 93.80M |
| Free Cash Flow Yield | 5.73% |